Replit, Kilo Code, and Symbotic engineering leaders reveal how they track AI coding costs and stop runaway token spend before ...

Replimune (REPL) more than doubles in value as FDA advisers back the company's lead drug, RP1, setting up a potential ...

The Disrupt Stage is where many of the biggest conversations in technology happen, with a legacy that stretches back for more ...

The scale of AI-generated media can be hard to grasp. Starling Lab, a research collaboration from Stanford University and the ...

As far as Dusty Crum is aware, his Florida restaurant is the only pizza place in the world that accepts invasive Burmese pythons as currency. It's his way of supporting the Florida Python Challenge, ...

The Florida Python Challenge is an annual competition to help control the invasive Burmese python population. Hunters must humanely kill captured pythons, and decapitation is not considered a humane ...

If Python developers have one consistent gripe about their beloved language, it tends to be this: Why is it so hard to take a Python program and deploy it as a standalone artifact, the way C, C++, ...

In July 2025, REPL announced it had received a CRL for its biologics license application (BLA) for RP1 (vusolimogene oderparepvec) plus nivolumab in advanced melanoma patients who were PD-1 ...

Sorry to burst your bubble right off the bat, but the show hasn’t even been renewed yet. While Welcome to Derry had a strong start, that number quickly fell off in subsequent episodes. That said, it’s ...

Fintel reports that on November 3, 2025, BMO Capital upgraded their outlook for Replimune Group (NasdaqGS:REPL) from Underperform to Market Perform. As of October 30, 2025, the average one-year price ...

Learning Python can feel like a big task, but with the freeCodeCamp Python curriculum, it gets a lot easier. I remember when I first tried to learn Python, I bounced between tutorials, books, and ...

Fintel reports that on October 20, 2025, JP Morgan upgraded their outlook for Replimune Group (NasdaqGS:REPL) from Underweight to Neutral. As of September 30, 2025, the average one-year price target ...